469-38-5Relevant articles and documents
Enzyme redesign: Two mutations cooperate to convert cycloartenol synthase into an accurate lanosterol synthase
Lodeiro, Silvia,Schulz-Gasch, Tanja,Matsuda, Seiichi P. T.
, p. 14132 - 14133 (2005)
Efforts to modify the catalytic specificity of enzymes consistently show that it is easier to broaden the substrate or product specificity of an accurate enzyme than to restrict the selectivity of one that is promiscuous. Described herein are experiments in which cycloartenol synthase was redesigned to become a highly accurate lanosterol synthase. Several single mutants have been described that modify the catalytic specificity of cycloartenol to form some lanosterol. Modeling studies were undertaken to identify combinations of mutations that cooperate to decrease the formation of products other than lanosterol. A double mutant was constructed and characterized and was shown to cyclize oxidosqualene accurately to lanosterol (99%). This catalytic change entailed both relocating polarity with a His477Asn mutation and modifying steric constraints with an Ile481Val mutation. Copyright
Directed evolution to investigate steric control of enzymatic oxidosqualene cyclization. An isoleucine-to-valine mutation in cycloartenol synthase allows lanosterol and parkeol biosynthesis [9]
Hart, Elizabeth A.,Hua, Ling,Darr, Lisa B.,Wilson, William K.,Pang, Jihai,Matsuda, Seiichi P. T.
, p. 9887 - 9888 (1999)
-
DRUGS, FOOD OR DRINK FOR IMPROVING PANCREATIC FUNCTIONS
-
Page/Page column 14, (2008/06/13)
Compounds having a cyclolanostane skeleton such as 9,19-cyclolanostan-3-ol and 24-methylene-9,19-cyclolanostan-3-ol are used as an active ingredient of a drug and food or drink for improving pancreatic functions.